The potential of natural products to inhibit abnormal aggregation of α-Synuclein in the treatment of Parkinson's disease.
Yang K, Lv Z, Zhao W, Lai G, Zheng C, Qi F, Zhao C, Hu K, Chen X, Fu F, Li J, Xie G, Wang H, Wu X, Zheng W.
Yang K, et al. Among authors: qi f.
Front Pharmacol. 2024 Oct 23;15:1468850. doi: 10.3389/fphar.2024.1468850. eCollection 2024.
Front Pharmacol. 2024.
PMID: 39508052
Free PMC article.
Review.